Philadelphia Pharmaceuticals Company (ASE:PHIL)
Jordan · Delayed Price · Currency is JOD 1.600
0.00 (0.00%)
At close: Dec 31, 2025
ASE:PHIL Cash Flow Statement
Financials in millions JOD. Fiscal year is January - December.
Millions JOD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | 0.91 | 0.82 | 0.81 | 0.7 | 0.41 | 0.14 | Upgrade |
Depreciation & Amortization | 0.02 | 0.28 | 0.29 | 0.12 | 0.16 | 0.28 | Upgrade |
Other Amortization | 0.52 | 0.3 | 0.3 | 0.25 | 0.1 | 0.03 | Upgrade |
Loss (Gain) From Sale of Assets | - | -0.01 | - | - | - | - | Upgrade |
Provision & Write-off of Bad Debts | - | - | - | - | 0.01 | 0.02 | Upgrade |
Other Operating Activities | 0.41 | 0.36 | 0.37 | 0.27 | 0.57 | 0.17 | Upgrade |
Change in Accounts Receivable | -0.56 | 0.07 | -0.2 | 0.46 | 1.94 | 1.25 | Upgrade |
Change in Inventory | -0.16 | -0.01 | -0.48 | 0.25 | 0.46 | -0.23 | Upgrade |
Change in Accounts Payable | 0.21 | -0.13 | 0.22 | 0.04 | -0.14 | -0.13 | Upgrade |
Change in Other Net Operating Assets | 0 | 0.04 | -0.21 | 0.02 | -0.37 | 0.17 | Upgrade |
Operating Cash Flow | 1.36 | 1.72 | 1.1 | 2.11 | 3.15 | 1.7 | Upgrade |
Operating Cash Flow Growth | -31.69% | 56.55% | -47.82% | -33.02% | 84.84% | 319.67% | Upgrade |
Capital Expenditures | 0.66 | -0.19 | -0.07 | -0.17 | -0.2 | -0.14 | Upgrade |
Sale of Property, Plant & Equipment | 0.03 | 0.03 | - | 0.03 | 0.04 | - | Upgrade |
Sale (Purchase) of Intangibles | - | - | -0.01 | -1.82 | -2.49 | - | Upgrade |
Sale (Purchase) of Real Estate | -0.92 | -0.92 | - | - | - | - | Upgrade |
Investing Cash Flow | -0.24 | -1.08 | -0.07 | -1.96 | -2.66 | -0.14 | Upgrade |
Short-Term Debt Issued | - | - | - | 0.38 | - | - | Upgrade |
Long-Term Debt Issued | - | 1.31 | - | - | - | - | Upgrade |
Total Debt Issued | 0.17 | 1.31 | - | 0.38 | - | - | Upgrade |
Short-Term Debt Repaid | - | -0.82 | -0.34 | - | -0.19 | -0.52 | Upgrade |
Total Debt Repaid | -0.37 | -0.82 | -0.34 | - | -0.19 | -0.52 | Upgrade |
Net Debt Issued (Repaid) | -0.2 | 0.49 | -0.34 | 0.38 | -0.19 | -0.52 | Upgrade |
Common Dividends Paid | -0.53 | -0.53 | -0.45 | -0.45 | - | -0.38 | Upgrade |
Other Financing Activities | -0.3 | -0.35 | -0.34 | -0.24 | -0.23 | -0.3 | Upgrade |
Financing Cash Flow | -1.02 | -0.38 | -1.12 | -0.31 | -0.43 | -1.19 | Upgrade |
Net Cash Flow | 0.1 | 0.25 | -0.1 | -0.16 | 0.06 | 0.37 | Upgrade |
Free Cash Flow | 2.01 | 1.53 | 1.03 | 1.94 | 2.94 | 1.56 | Upgrade |
Free Cash Flow Growth | 120.53% | 47.69% | -46.74% | -34.02% | 88.22% | 1073.41% | Upgrade |
Free Cash Flow Margin | 22.10% | 17.43% | 12.30% | 23.07% | 44.57% | 20.42% | Upgrade |
Free Cash Flow Per Share | 0.27 | 0.20 | 0.14 | 0.26 | 0.39 | 0.21 | Upgrade |
Cash Interest Paid | - | - | - | - | 0.23 | - | Upgrade |
Cash Income Tax Paid | 0.13 | 0.22 | 0.18 | 0.13 | 0.02 | 0.16 | Upgrade |
Levered Free Cash Flow | 1.51 | 1.01 | 0.52 | -0.28 | -0.16 | 1.2 | Upgrade |
Unlevered Free Cash Flow | 1.7 | 1.24 | 0.73 | -0.13 | -0.02 | 1.39 | Upgrade |
Change in Working Capital | -0.51 | -0.02 | -0.67 | 0.77 | 1.9 | 1.06 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.